期刊文献+

2型糖尿病视网膜病变与血清中TG/HDL比值关系研究 被引量:7

Relationship between serum triglyceride/high-density and its clinical significance in type 2 diabetic retinopathy
原文传递
导出
摘要 目的探讨血清中甘油三脂与高密度脂蛋白(TG/HDL)比值与糖尿病视网膜病变之间的关系及临床意义。方法临床病例对照研究。对2011年11月至2012年5月在郑州大学第一附属医院眼科就诊的131例内分泌科住院的2型糖尿病病人按眼底照相所见分为三组,其中非糖尿病视网膜病变组(NDR)28例,非增值型糖尿病视网膜病变(NPDR)组85例,增值性糖尿病视网膜病变(PDR)18例。检测并评估总胆固醇(CHOL)、甘油三脂(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)及载脂蛋白A1(APOPA1)、载脂蛋白B100(APOB100)及TG/HDL值;及其他可能影响糖尿病视网膜病变进展的相关临床指标。结果NDR组、NPDR组和PDR的TG/HDL值分别为(2.79±1.11)、(2.85±0.83)和(4.00±1.72),三组之间TG/HDL比值的差异有统计学意义(P〈0.001),Logis-tic回归分析显示TG/HDL比值与糖尿病视网膜病变程度呈明显正相关(B=1.795,P=0.032)。结论TG/HDL比值可作为评估糖尿病视网膜病变的一个有效指标,有助于糖尿病视网膜病变的早期诊断和治疗。 Objective To investigate the relationship between serum triglyceride/high-density lipo- protein cholesterol (TG/HDL) ratio with Type 2 diabetic retinopathy and its clinical significance. Methods One hundred and thirty-one patients with Type 2 diabetes mellitus were divided into three groups according to their fundus condition, 28 patients with no diabetic retinopathy (NDR), 85 with non-proliferative diabetic retinopathy (NPDR), 18 with proliferative diabetic retinopathy (PDR). Clini- cal parameters related to the progression of DR, including cholesterol triglycerides (TG), high-density lipoprotein cholesterol (HDL), LDL, and apolipoproteinAI (apoAI), apolipoproteinB (apoB), TG/HDL were determined and assessed. Results TG/HDL ratio was 2.79±1.11, 2.85±0.83 and 4.00±1.72 in NDR, NPDR and PDR group respectively. Difference of TG/HDL ratio among the three groups were statistical significance (P 〈0.001). Logistic regression analysis showed a positive correlation displayed between TG/HDL ratio and DR (B =1.795, P =0.032). Conclusions TG/HDL ratio may be used as an effective indicator for the assessment and treatment of DR.
出处 《中国实用眼科杂志》 CSCD 北大核心 2013年第7期831-833,共3页 Chinese Journal of Practical Ophthalmology
关键词 2型糖尿病 糖尿病视网膜病变 TG HDL比值 Type 2 diabetes Mellitus diabetic retinopathy Triglyceride /High-density lipopro- tein cholesterol
  • 相关文献

参考文献12

  • 1Yang W,Lu J,Weng JP,et al. Prevalence of diabetes amongmen and women in China [J].N Engl J Med,2010,25,362:1090-1101.
  • 2Cheung N,Wong TY. Diabetic retinopathy and systemic vascu-lar complications [J].Progress Retinal and Eye Research,2008,27(2):161-176.
  • 3Ferris FL,Chew EY,Hoogwerf BJ.Serum Lipid and Diabetic Ret-inopathy [J].Commentary,1996,19(11):1291-1293.
  • 4Oivarius N,Nielsen N,Andreasen A.Diabetic retinopathy innewly diagnose middle-aged and elderly diabetic patients.preva-lence and interrelationship with microalbumminuria and triglyc-erides [J].Graefes Arch Clin Exp Ophthalmol,2001,239 (19):664-672.
  • 5李晨钟,张素华,汪湘琳,肖谦,汪志红.糖尿病视网膜病变与脂质代谢紊乱的关系[J].中华眼底病杂志,1998,14(1):21-23. 被引量:15
  • 6常家巍,高永峰.2型糖尿病视网膜病变血清C肽测定及临床意义[J].中国实用眼科杂志,2011,29(4):337-340. 被引量:9
  • 7Yuzo D,Takatoshi M,Yoshitsugu S,et al. Relevance of the se-rum apolipoprotein ratio to diabetic retinopathy [J].Jpn J Oph-thalmol,2011,55(2):128-131.
  • 8Nicholls SJ,Tuzcu EM,Wolski K,et al. Lowering the triglycer-ide/high-density lipoprotein cholesterol ratio is associated withthe beneficial impact of pioglitazone on progression of coronaryatherosclerosis in diabetic patients [J].J Am Coll Cardiol,2011,57(2):153-159.
  • 9Giacomo Z,Carlo N. Triglyceride-high-density lipoprotein cho-lesterol is associated with microvascular complications in type.2diabetes mellitus[J].Metabolism,2012,61(1):22-29.
  • 10Keech AC,Mitchell P,Summanen PA,et al.Effect of fenofibrateon the need for laser treatment for diabetic retinopathy (FIFLDstudy):a randomised controlled trial [J].Lancet,2007,370(9600):1687-1697.

二级参考文献23

  • 1Bo S,Cavallo-Perin P,Gentile L,et al.Relationship of residual beta-cell function,metabolic control and chronic complications in type 2diabetes mellitns[J].Acta Diabetol,2000,37(3):126-129.
  • 2Subhan SS,Bhuiyan ZI,Akter K,et al.Relation between insulin secretory capacity and microangiopathy in young diabetes patients in Bangladesh[J].Myrnensingh Med J,2007,16(1):1-6.
  • 3Johansson BL,Kernell A,Wahren J.Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1[J].J Clin Endocrinol Metab,1993,77 (4):976-981.
  • 4Ido Y,Vindigni A,Chang K,et al.Prevention of vascular and neural dysfunction in diabetic rats by C-peptide[J].Science,1997,277(5325):563-566.
  • 5Ekberg K,Juntti-Berggren L,Norrby A,et al.C-peptide improves sensory nerve function in type 1 diabetes and neuropathy[J].Diabetologia,2005,48(suppl 1):81.
  • 6Thompson DM,Begg IS,Harris C,et al.Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy[J].Transplantation,2008,85(10):1400-1405.
  • 7Venturini M,Fiorina P,Maffi P,et al.Early increase of retinal arterial and venous blood flow velocities at color doppler imaging in brittle type 1 diabetes after islet transplant alone[J].Transplantation,2006,81:1274-1277.
  • 8Klein R,Klein BE,Moss SE.The Wisconsin Epidemiologic Study of Diabetic Retinopathy.XVI.The relationship of C-peptide to the incidence and progression of diabetic retinopathy[J].Diabetes,1995,44:796-801.
  • 9Nordwall M,Arnqvist HJ,Bojestjg M,et al.Good glycemic control remains crucial in prevention of late diabetic complications-the Linkoping Diabetes Complications Study[J].Pediatric Diabetes,2009,10(3):168-176.
  • 10Stratton IM,Kohner EM,Aldington SJ,et al.UKPDS 50:risk factors for incidence and progression of retinopathy in type Ⅱ diabetes over 6 years from diagnosis[J].Diabetologia,2001,44:156-163.

共引文献22

同被引文献57

引证文献7

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部